Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
12/1999
12/14/1999US6001799 Method of treating hepatitis C in non-responders to interferon treatment
12/14/1999US6001647 In vitro growth of functional islets of Langerhans and in vivo uses thereof
12/14/1999US6001601 Methionyl tRNA synthetase polynucleotides
12/14/1999US6001557 Polycation conjugate coding defective virus which reduces the packaging efficiency virus, a minigene and sequences which allow for efficiect viral infection; for gene therapy
12/14/1999US6001387 Spin disk encapsulation apparatus and method of use
12/14/1999US6001361 For the prevention, treatment and diagnosis of mycobacterial infection, together with adjuvants for use in vaccines or immunotherapy of infectious diseases and cancers; for preventing, treating and detecting tuberculosis
12/14/1999US6001360 Glutamic acid decarboxylase (gad) proteins and fragments thereof are administered to an animal in order to the reduce the severity of diabetes
12/14/1999US6001352 Contacting condrocytes with specific platelet-derived growth factors (pdgf) in the absence of growth factors which promote cell differentiation; cells cultured and loaded onto scaffolding for implanting into a cartilage or bone wound
12/14/1999US6001351 Macrophages, process for preparing the same and their use as active substances of pharmaceutical compositions
12/14/1999US6001349 Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof
12/14/1999US6001348 An nad (nicotinamide-adenine dinucleotide)-independent live attenuated strain of mycoplasma synoviae; and less expensive vaccines for protecting poultry against mycoplasma synoviae
12/14/1999US6001312 Reactor for making uniform capsules
12/14/1999US6001259 Preparation of autologous plasma and fibrin gel
12/14/1999CA2186526C Method and product for regulating cell responsiveness to external signals
12/14/1999CA2155024C Genetic modification of neural stem cells
12/14/1999CA1340852C Process for purifying primate gm-csf protein
12/09/1999WO1999063101A2 Transfected cells and methods for treating diabetes
12/09/1999WO1999063050A2 Method for preparation and in vivo administration of antigen presenting cell composition
12/09/1999WO1999062561A2 Gene therapy method
12/09/1999WO1999062558A1 Insulin supplemented infant formula
12/09/1999WO1999062527A1 nrdE
12/09/1999WO1999062473A1 Use of micro-organism extracts in cosmetic or pharmaceutical compositions
12/09/1999WO1999062451A1 Topical transdermal treatments
12/09/1999WO1999051275A3 Mesenchymal stem cells as immunosuppressants
12/09/1999WO1999048506A3 Composition containing at least one metal yeast for pharmaceutical use and/or for use as a nutrition supplement, for humans or animals
12/09/1999WO1999046367A3 Methods of diagnosis and triage using cell activation measures
12/09/1999WO1999044943A3 Vectors and viruses used in gene therapy
12/09/1999WO1999038973A3 Compounds for therapy and diagnosis of lung cancer and methods for their use
12/09/1999DE19825620A1 Verwendung von adenoassoziierten Viren zur Senkung der radio- oder chemotherapieinduzierten Resistenz bei Krebspatienten Adeno-associated viruses use to reduce radio- or chemotherapy-induced resistance in cancer patients
12/09/1999DE19825419A1 Production of high porosity solid useful as bone substitute
12/09/1999CA2334171A1 Gene therapy method
12/09/1999CA2333903A1 Topical transdermal treatments
12/09/1999CA2330027A1 Method for preparation and in vivo administration of antigen presenting cell composition
12/08/1999EP0961780A1 Protein markers for lung cancer and use thereof
12/08/1999EP0634934B1 Use of dietary whey proteins for the treatment of hiv-seropositive individuals
12/08/1999EP0522078B1 Gp75 as a tumor vaccine for melanoma
12/08/1999CN1237909A Cancer immunotherapy using tumor cells combined with mixed lymphocytes
12/08/1999CN1237881A Method and compositions for increasing anaerobic working capacity in tissues
12/08/1999CN1237451A Enema liquor for woman pelvic inflammation
12/08/1999CN1237429A Medicine for curing tumor and its preparation method
12/08/1999CN1237427A Adhesive plaster for curing prolapse of lumbar intervertebral disk
12/08/1999CN1237422A Preparation process of insect protein capsule or powder
12/08/1999CN1237421A Preparation method of liquid donkey-hide gelatin by zymohydrolysis
12/08/1999CN1047203C Enzymolytic hydrolytic ovalbumin solution and its preparing method and use
12/08/1999CN1047086C Poultry antibiotic Chinese patent drug and its preparing method
12/08/1999CN1047085C Medicine for curing syphilis and gonorrhoea, and its preparing method
12/07/1999US5998587 Anti-cyanovirin antibody
12/07/1999US5998205 Vectors for tissue-specific replication
12/07/1999US5998192 For use in many human gene therapy protocols, especially those requiring transduction of normal or neoplastic haemopoietic cells.
12/07/1999US5997943 Compound for a non-wettable coating, process for treatment of glass with the aid of the compound and products obtained
12/07/1999US5997909 Composition containing a complex of a polyvalent metal and a DNA-sodium salt
12/07/1999US5997908 Prostate extract supplemented with zinc
12/07/1999US5997900 High viscosity sodium alginate, cellulose sulfate, and poly(methylene-co-guanidine)hydrochloride, calcium chloride or sodium chloride.
12/07/1999US5997885 Cosmetic and/or dermatological composition containing thermal spring water or mineral water and an active agent, in order to combat acne or aging
12/07/1999US5997880 Method for alleviating varicella related post-herpetic neuralgia
12/07/1999US5997878 Recombinant poxvirus-cytomegalovirus, compositions and uses
12/07/1999US5997870 Isolated peptides which bind to HLA-B44 Molecules
12/07/1999CA2155928C Plastic articles of reduced gas transmission and method therefor
12/07/1999CA1340839C Proteins and process for preparing them, dna sequences, antibodies and uses thereof, posvirus, altered or infected cells, pharmaceutical compositions useful for the prevention of schistosomosis and uses thereof as an agent with a glutathion-s-transferase activity
12/02/1999WO1999061645A1 Novel compound, wf00144
12/02/1999WO1999061639A2 Retroviral delivery system
12/02/1999WO1999061638A1 Chimeric adenoviral vectors
12/02/1999WO1999061636A1 Recombinant cytomegalovirus expression system targeting the immediate-early gene region
12/02/1999WO1999061625A1 Mycobacterial n-acetyltransferases
12/02/1999WO1999061621A1 Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4
12/02/1999WO1999061595A2 Adeno-associated viral vector-mediated expression of factor viii activity
12/02/1999WO1999061589A2 Expansion of hematopoietic stem cells transduced with mdr-1 and methods of use thereof
12/02/1999WO1999061588A1 Production of megakaryocytes by co-culturing human mesenchymal stem cells with cd34+ cells
12/02/1999WO1999061587A1 Human cd45+ and/or fibroblast + mesenchymal stem cells
12/02/1999WO1999061586A1 Promotion of cell differentiation by initially passaged cells
12/02/1999WO1999061584A1 Compositions and methods for use in affecting hematopoietic stem cell populations in mammals
12/02/1999WO1999061468A2 The induction of antibiotic peptides by lait (scd14) protein
12/02/1999WO1999061085A2 Method and compositions for treatment of cancers
12/02/1999WO1999061066A2 Convection-enhanced delivery of aav vectors
12/02/1999WO1999061065A1 Cd40 binding molecules and ctl peptides for treating tumors
12/02/1999WO1999061052A2 Oral immunization with papillomavirus virus-like particles
12/02/1999WO1999061035A1 Preparation based on the artichoke plant, especially for use as a medicament or food supplement
12/02/1999WO1999061011A2 Use of a medicine containing a quantity of tyrothricine for the treatment of viral infections
12/02/1999WO1999060951A1 Compositions for regenerating tissue that has degenerated, and methods for using such compositions
12/02/1999WO1999060846A1 Method for expanding primate b cells selectively in immunocompromised mice and producing large numbers of antigen-specific b lymphocytes for the production of primate monoclonal antibodies
12/02/1999WO1999053942A8 Compositions comprising osteoprotegerin for the prevention and treatment of cardiovascular diseases
12/02/1999WO1999050413A3 Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the tnf receptor superfamily
12/02/1999WO1999046381A9 Human fgf gene and gene expression products
12/02/1999WO1999045938B1 Thrombin preparation and products and fibrin sealant methods employing same
12/02/1999WO1999043286A3 Isolated stromal cells for use in the treatment of diseases of the central nervous system
12/02/1999DE19823318A1 Verwendung eines Arzneimittels mit einem Gehalt an Tyrothricin zur Behandlung von Virusinfektionen Use of a pharmaceutical having a content of tyrothricin for the treatment of viral infections
12/02/1999CA2333702A1 Promotion of cell differentiation by initially passaged cells
12/02/1999CA2332336A1 Method for expanding primate b cells selectively in immunocompromised mice and producing large numbers of antigen-specific b lymphocytes for the production of primate monoclonal antibodies
12/02/1999CA2329143A1 Adeno-associated viral vector-mediated expression of factor viii activity
12/02/1999CA2329136A1 Oral immunization with papillomavirus virus-like particles
12/02/1999CA2328524A1 Human cd45+ and/or fibroblast + mesenchymal stem cells
12/02/1999CA2328491A1 Retroviral delivery system
12/02/1999CA2328451A1 Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4
12/02/1999CA2328425A1 Production of megakaryocytes by co-culturing human mesenchymal stem cells with cd34+ cells
12/02/1999CA2328134A1 The induction of antibiotic proteins and peptides by lait/scd14-protein
12/02/1999CA2298064A1 Chimeric adenoviral vectors
12/01/1999EP0960115A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS AN ONCOGENE
12/01/1999EP0959903A1 NOVEL FabD
12/01/1999EP0959892A1 Use of pvp or povidone for reducing bowel distension
12/01/1999EP0822845A4 Systems and methods for on-line finishing of cellular blood products like platelets harvested for therapeutic purposes